Anti-Ebola MVA vaccine using a cell line

Anti-Ebola MVA vaccine using a cell line

A vaccine against Ebola virus using a safe, cost-effective, fully scalable AGE1.CR.pIX® duck cell line developed by ProBioGen is into clinical trials at Jenner Institute. Vaccines from this process promise a very large scale production to meet the urgent needs worldwide.


How to cite this article:
Hameedunissa Begum Shariff. Anti-Ebola MVA vaccine using a cell line. BioLim O-Media. 24 November, 2016. 4(11).
Available from: http://archive.biolim.org/omedia/read/BOMA0148.